Letters to the Editor

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Haemostasis and Thrombosis Unit, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Haemostasis and Thrombosis Unit, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Clinical Trials Unit (AGDAC), Haematology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Clinical Trials Unit (AGDAC), Haematology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Clinical Pharmacology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain; Drug Research Centre, Institut d'Investigació Biomèdica Sant Pau, IIB-Sant Pau, Barcelona
Genomics of Complex Diseases Unit, Research Institute of Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Blood and Tissue Bank (BST), Barcelona, Spain 7Haematology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Haematology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Clinical Pharmacology Service, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain; Drug Research Centre, Institut d'Investigació Biomèdica Sant Pau, IIB-Sant Pau, Barcelona
Haemostasis and Thrombosis Unit, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona
Haematologica Early view May 12, 2022 https://doi.org/10.3324/haematol.2022.281068